广发纳斯达克生物科技人民币(001092)

动态评分: 5.86分

投资组合

报告日期 名称 比例
2015-12-31 奥尔巴尼分子研究 0.09%
2015-12-31 Atara Biotherapeutics Inc 0.09%
2015-12-31 BioCryst Pharmaceuticals Inc 0.09%
2015-12-31 Blueprint Medicines Corp 0.09%
2015-12-31 Foundation Medicine Inc 0.09%
2015-12-31 杰龙 0.09%
2015-12-31 Sucampo Pharmaceuticals Inc-A 0.09%
2015-12-31 Aerie Pharmaceuticals Inc 0.08%
2015-12-31 Amphastar Pharmaceuticals Inc 0.08%
2015-12-31 Epizyme Inc 0.08%
2015-12-31 OncoMed Pharmaceuticals Inc 0.08%
2015-12-31 Otonomy Inc 0.08%
2015-12-31 Sangamo Therapeutics Inc 0.08%
2015-12-31 Synergy Pharmaceuticals Inc 0.08%
2015-12-31 Supernus Pharmaceuticals Inc 0.08%
2015-12-31 Travere Therapeutics Inc 0.08%
2015-12-31 Array BioPharma Inc 0.07%
2015-12-31 Cerus Corp 0.07%
2015-12-31 Collegium Pharmaceutical Inc 0.07%
2015-12-31 Enanta Pharmaceuticals Inc 0.07%

投资模拟

公告&资料